Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sara Boyce & Savita Rangarajan. (2023) RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection. Journal of Blood Medicine 14, pages 317-327.
Read now
Read now
Suvankar Banerjee, Shristi Kejriwal, Balaram Ghosh, Goverdhan Lanka, Tarun Jha & Nilanjan Adhikari. (2023) Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-17.
Read now
Read now
Chaudry Nasir Majeed, Christopher D Ma, Ted Xiao, Sean Rudnick & Herbert L Bonkovsky. (2022) Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy. Drug Design, Development and Therapy 16, pages 1827-1845.
Read now
Read now
Vijay Chaitanya Ganta & Brian H. Annex. (2021) Peripheral vascular disease: preclinical models and emerging therapeutic targeting of the vascular endothelial growth factor ligand-receptor system. Expert Opinion on Therapeutic Targets 25:5, pages 381-391.
Read now
Read now
Bozho Todorich, Glenn Yiu & Paul Hahn. (2014) Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis. Expert Review of Clinical Pharmacology 7:3, pages 375-391.
Read now
Read now
Qiang Shen, Mack H Wu & Sarah Y Yuan. (2009) Endothelial contractile cytoskeleton and microvascular permeability. Cell Health and Cytoskeleton 1, pages 43-50.
Read now
Read now
Articles from other publishers (41)
Ramani Ramchandran. (2022) Endothelial cells and their role in the vasculature: Past, present and future. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Alireza Shoari, Mehdi Tahmasebi, Farnaz Khodabakhsh, Reza Ahangari Cohan, Akbar Oghalaie & Mahdi Behdani. (2022) Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates. International Immunopharmacology 105, pages 108585.
Crossref
Crossref
Ge Yang & Yuanyu Huang. 2021. Aptamers for Medical Applications. Aptamers for Medical Applications
129
178
.
Felcia Lai, Bryson A. Hawkins, Esteban Cruz, Jane R. Hanrahan, Paul W. Groundwater & David E. Hibbs. 2020. Biologics, Biosimilars, and Biobetters. Biologics, Biosimilars, and Biobetters
71
88
.
Bo Hu, Liping Zhong, Yuhua Weng, Ling Peng, Yuanyu Huang, Yongxiang Zhao & Xing-Jie Liang. (2020) Therapeutic siRNA: state of the art. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Farkhondeh Chaharband, Narsis Daftarian, Mozhgan Rezaei Kanavi, Reyhaneh Varshochian, Maliheh Hajiramezanali, Parisa Norouzi, Ehsan Arefian, Fatemeh Atyabi & Rassoul Dinarvand. (2020) Trimethyl chitosan-hyaluronic acid nano-polyplexes for intravitreal VEGFR-2 siRNA delivery: Formulation and in vivo efficacy evaluation. Nanomedicine: Nanotechnology, Biology and Medicine 26, pages 102181.
Crossref
Crossref
Yuhua Weng, Haihua Xiao, Jinchao Zhang, Xing-Jie Liang & Yuanyu Huang. (2019) RNAi therapeutic and its innovative biotechnological evolution. Biotechnology Advances 37:5, pages 801-825.
Crossref
Crossref
Akash Chandela & Yoshihito Ueno. (2019) Systemic Delivery of Small Interfering RNA Therapeutics: Obstacles and Advances. Reviews in Agricultural Science 7:0, pages 10-28.
Crossref
Crossref
Anna-Kaisa Rimpelä, Iiro Kiiski, Feng Deng, Heidi Kidron & Arto Urtti. (2018) Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments. Pharmaceutics 11:1, pages 9.
Crossref
Crossref
Biplab Sarkar, Peter K. Nguyen, William Gao, Akhil Dondapati, Zain Siddiqui & Vivek A. Kumar. (2018) Angiogenic Self-Assembling Peptide Scaffolds for Functional Tissue Regeneration. Biomacromolecules 19:9, pages 3597-3611.
Crossref
Crossref
Forouhe Zahir-Jouzdani, Fatemeh Mottaghitalab, Meshkat Dinarvand & Fatemeh Atyabi. (2018) siRNA delivery for treatment of degenerative diseases, new hopes and challenges. Journal of Drug Delivery Science and Technology 45, pages 428-441.
Crossref
Crossref
Arnout Everaert, Yannick Wouters, Eline Melsbach, Nadia Zakaria, Annick Ludwig, Filip Kiekens & Wim Weyenberg. (2017) Optimisation of HPMC ophthalmic inserts with sustained release properties as a carrier for thermolabile therapeutics. International Journal of Pharmaceutics 528:1-2, pages 395-405.
Crossref
Crossref
Jiehua Zhou & John Rossi. (2016) Aptamers as targeted therapeutics: current potential and challenges. Nature Reviews Drug Discovery 16:3, pages 181-202.
Crossref
Crossref
Roshan AshoorDong LeeAlvan ChengBart JessenWenhu Huang. (2016) Validation of Cross-Species Reactivity of the VEGF-A/PDGFRβ Bifunctional Antibody PF-06653157. Journal of Ocular Pharmacology and Therapeutics 32:10, pages 650-658.
Crossref
Crossref
Daniel P. Potaczek, Holger Garn, Sebastian D. Unger & Harald Renz. (2016) Antisense molecules: A new class of drugs. Journal of Allergy and Clinical Immunology 137:5, pages 1334-1346.
Crossref
Crossref
Svetlana V. Kyosseva. (2016) Targeting MAPK Signaling in Age-Related Macular Degeneration. Ophthalmology and Eye Diseases 8, pages OED.S32200.
Crossref
Crossref
Huabing ZhangSadeesh K. RamakrishnanDaniel TrinerBrook CentofantiDhiman MaitraBalázs GyőrffyJudith S. Sebolt-LeopoldMichael K. DameJames VaraniDean E. BrennerEric R. FearonM. Bishr OmaryYatrik M. Shah. (2015) Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Science Signaling 8:397.
Crossref
Crossref
Wan‐Jen Yang, Junhao Hu, Akiyoshi Uemura, Fabian Tetzlaff, Hellmut G Augustin & Andreas Fischer. (2015) Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis. EMBO Molecular Medicine 7:10, pages 1267-1284.
Crossref
Crossref
F. Ramazani, C. Hiemstra, R. Steendam, F. Kazazi-Hyseni, C.F. Van Nostrum, G. Storm, F. Kiessling, T. Lammers, W.E. Hennink & R.J. Kok. (2015) Sunitinib microspheres based on [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers for ocular drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 95, pages 368-377.
Crossref
Crossref
Arnout Everaert, G?raldine Broeckx, Erik Fransen, Annick Ludwig, Filip Kiekens & Wim Weyenberg. (2015) Evaluation of a newly developed HPMC ophthalmic insert with sustainehttp://10.10.23.106:8080/TDXPSLIVEGANG/gateway/elsevierjournal/index.jsp#d release properties as a carrier for thermolabile therapeutics. International Journal of Pharmaceutics 481:1-2, pages 37-46.
Crossref
Crossref
Svetlana V Kyosseva. (2015) Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases. World Journal of Ophthalmology 5:1, pages 23.
Crossref
Crossref
Mélanie Guyot & Gilles Pagès. 2015. VEGF Signaling. VEGF Signaling
3
23
.
Tiejun LiMeihua WuYork Yuanyuan ZhuJianxin ChenLi Chen. (2014) Development of RNA Interference–Based Therapeutics and Application of Multi-Target Small Interfering RNAs. Nucleic Acid Therapeutics 24:4, pages 302-312.
Crossref
Crossref
Matt Gooding, Derick Adigbli, A. W. Edith Chan, Roberta J. Melander, Alexander J. MacRobert & David L. Selwood. (2014) A Bifurcated Proteoglycan Binding Small Molecule Carrier for siRNA Delivery. Chemical Biology & Drug Design 84:1, pages 24-35.
Crossref
Crossref
Anton M. Kolomeyer & Marco A. Zarbin. (2014) Trophic factors in the pathogenesis and therapy for retinal degenerative diseases. Survey of Ophthalmology 59:2, pages 134-165.
Crossref
Crossref
Giulio Ferrari, Mohammad H. Dastjerdi, Andre Okanobo, Sheng-Fu Cheng, Francisco Amparo, Nambi Nallasamy & Reza Dana. (2013) Topical Ranibizumab as a Treatment of Corneal Neovascularization. Cornea 32:7, pages 992-997.
Crossref
Crossref
David J. Bruce & Peng H. Tan. 2013. Biochemical Basis and Therapeutic Implications of Angiogenesis. Biochemical Basis and Therapeutic Implications of Angiogenesis
3
22
.
Farbod Shojaei. (2012) Anti-angiogenesis therapy in cancer: Current challenges and future perspectives. Cancer Letters 320:2, pages 130-137.
Crossref
Crossref
Dong U. LeeWenhu HuangKay D. RittenhouseBart Jessen. (2012)
Retina Expression and Cross-Species Validation of Gene Silencing by PF-655, a Small Interfering RNA Against
RTP801
for the Treatment of Ocular Disease
. Journal of Ocular Pharmacology and Therapeutics 28:3, pages 222-230.
Crossref
Crossref
Victoria A. Meliopoulos, Lauren E. Andersen, Paula Brooks, Xiuzhen Yan, Abhijeet Bakre, J. Keegan Coleman, S. Mark Tompkins & Ralph A. Tripp. (2012) MicroRNA Regulation of Human Protease Genes Essential for Influenza Virus Replication. PLoS ONE 7:5, pages e37169.
Crossref
Crossref
Hamidreza M. Aliabadi, Breanne Landry, Chongbo Sun, Tian Tang & Hasan Uludağ. (2012) Supramolecular assemblies in functional siRNA delivery: Where do we stand?. Biomaterials 33:8, pages 2546-2569.
Crossref
Crossref
Won ChoiHwan Heo. (2012) Effect of Laser Photocoagulation and Intravitreal Bevacizumab Injection on Zone I Retinopathy of Prematurity. Journal of the Korean Ophthalmological Society 53:1, pages 120.
Crossref
Crossref
Anne R. Murray & Jian-xing Ma. 2012. Visual Dysfunction in Diabetes. Visual Dysfunction in Diabetes
245
259
.
Willemijn B. Breunis, Sonia Davila, Chisato Shimizu, Toshiaki Oharaseki, Kei Takahashi, Michel van Houdt, Chiea Chuen Khor, Victoria J. Wright, Michael Levin, Jane C. Burns, David Burgner, Martin L. Hibberd & Taco W. Kuijpers. (2012) Disruption of vascular homeostasis in patients with Kawasaki disease: Involvement of vascular endothelial growth factor and angiopoietins. Arthritis & Rheumatism 64:1, pages 306-315.
Crossref
Crossref
Juan Liu, Purushottam Jha, Valeriy V. Lyzogubov, Ruslana G. Tytarenko, Nalini S. Bora & Puran S. Bora. (2011) Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal Neovascularization. Journal of Biological Chemistry 286:23, pages 20991-21001.
Crossref
Crossref
Michelle T. Marra, Penney Khamphavong, Peter Wisniecki, Hovhannes J. Gukasyan & Katsuhiko Sueda. (2011) Solution Formulation Development of a VEGF Inhibitor for Intravitreal Injection. AAPS PharmSciTech 12:1, pages 362-371.
Crossref
Crossref
Brandon N. Phillips & Keith J. Wroblewski. (2010) A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis. Journal of Ophthalmic Inflammation and Infection 1:1, pages 29-34.
Crossref
Crossref
S.G. Spain, G. Yaşayan, M. Soliman, F. Heath, A.O. Saeed & C. Alexander. 2011. Comprehensive Biomaterials. Comprehensive Biomaterials
389
410
.
. (2010) Current World Literature. Current Opinion in Ophthalmology 21:3, pages 239-246.
Crossref
Crossref
P. J. Simpson-Haidaris, S. J. Pollock, S. Ramon, N. Guo, C. F. Woeller, S. E. Feldon & R. P. Phipps. (2010)
Anticancer Role of PPAR
Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
. PPAR Research 2010, pages 1-36.
Crossref
Crossref
Hyun Joon LeeJoo Youn ParkYoung-Hoon Ohn. (2009) Electrophysiological and Morphological Changes After Intravitreal Bevacizumab Injection with Macular Edema or Choroidal Neovascularization. Journal of the Korean Ophthalmological Society 50:12, pages 1824.
Crossref
Crossref